Skip to search formSkip to main contentSkip to account menu

maribavir

Known as: benzimidavir, NTBC, 5,6-dichloro-2-isopropylamino-1-b-L-ribofuranosyl-1H-benzimidazole 
An orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of viral… 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

1263W94GW 257406X

Broader (2)

BenzimidazolesRibonucleosides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec.
Highly Cited
2011
Highly Cited
2011
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.
Highly Cited
2008
Highly Cited
2008
What counts? Volunteers and their organisations in the recording and monitoring of biodiversity
There is a pressing need for volunteer amateur naturalists to participate in data collection for biodiversity monitoring… 
Review
2006
Review
2006
The genetic tyrosinemias
The genetic tyrosinemias are characterized by the accumulation of tyrosine in body fluids and tissues. The most severe form of… 
Highly Cited
2004
Highly Cited
2004
Structure of the ferrous form of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis in complex with the therapeutic herbicide, NTBC.
Di- and triketone inhibitors of (4-hydroxyphenyl)pyruvate dioxygenase (HPPD) are both effective herbicides and therapeutics. The… 
Review
2001
Review
2001
The Pathophysiology and Treatment of Hereditary Tyrosinemia Type 1
  • M. Grompe
  • Seminars in liver disease (Print)
  • 2001
  • Corpus ID: 34701706
The topic of this review is hepatorenal tyrosinemia (hereditary tyrosinemia type 1 [HT1], or fumarylacetoacetate hydrolase… 
Review
2000
Review
2000
Nontransplant treatment of tyrosinemia.
Highly Cited
1999
Highly Cited
1999
Indications and outcome of liver transplantation in tyrosinaemia type 1
Abstract A retrospective analysis was performed on 17 patients presenting with tyrosinaemia type 1 (TT1) between 1989–1997; 7 pre… 
Review
1998
Review
1998
Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione)
In tyrosinaemia type I (McKusick 276700), fatal liver disease results either because of liver failure during infancy or early… 
Highly Cited
1992
Highly Cited
1992
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)